Ely Benaim, Chief Medical Officer at NovoCure Ltd (NVCR), sold 2,374 shares at $158.96 ($367K) on 2021-07-30, disclosed to the SEC on 2021-08-03.
Open-market sale of $367k NVCR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $158.96 | 651 | $103K | 28.2% |
| 2 | $158.96 | 651 | $103K | 28.2% |
| 3 | $149.38 | 536 | $80K | 21.8% |
| 4 | $149.38 | 536 | $80K | 21.8% |
| Total | $154.63 avg | 2,374 | $367K | 100% |
| Filing → |
| NVCR | SELL | 2022-05-12 | $531K | — | Filing → |
| NVCR | SELL | 2022-03-07 | $332K | — | Filing → |
| NVCR | SELL | 2021-08-04 | $139K | — | Filing → |